GoHealth (GOCO) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

GOCO Stock Forecast

GoHealth stock forecast is as follows: an average price target of $13.00 (represents a 13.04% upside from GOCO’s last price of $11.50) and

GOCO Price Target

GoHealth Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Mar 20, 2024	Frank Morgan	RBC Capital	-	-	27.95%	13.04%

Row per page

Go to

The latest GoHealth stock forecast, released on Mar 20, 2024 by Frank Morgan from RBC Capital, set a price target of $13.00, which represents a 27.95% increase from the stock price at the time of the forecast ($10.16), and a 13.04% increase from GOCO last price ($11.50).

GoHealth Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	1
Avg Price Target	-	-	$13.00
Last Closing Price	$11.50	$11.50	$11.50
Upside/Downside	-100.00%	-100.00%	13.04%

In the current month, the average price target of GoHealth stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to GoHealth's last price of $11.50. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

GoHealth Financial Forecast

GoHealth Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$276.70M	$132.04M	$142.78M	$183.16M	$69.38M	$133.05M	$158.65M	$270.59M	$245.14M	$211.73M	$196.90M	$204.18M	$445.92M	$163.36M	$127.06M
Avg Forecast	$161.59M	$156.09M	$150.77M	$145.63M	$356.39M	$122.13M	$121.86M	$181.39M	$324.34M	$106.92M	$141.79M	$180.15M	$363.88M	$138.25M	$116.36M	$184.98M	$358.04M	$146.78M	$133.90M	$159.99M	$527.64M	$199.36M	$178.64M	$175.37M	$436.40M	$168.88M	$124.30M
High Forecast	$168.88M	$163.13M	$157.57M	$152.20M	$372.47M	$127.64M	$127.36M	$189.58M	$341.60M	$110.05M	$148.19M	$180.15M	$364.25M	$144.49M	$121.61M	$193.33M	$374.19M	$146.78M	$133.90M	$159.99M	$527.64M	$199.36M	$178.64M	$175.37M	$436.40M	$168.88M	$124.30M
Low Forecast	$156.86M	$151.51M	$146.35M	$141.37M	$345.95M	$118.55M	$118.29M	$176.08M	$315.17M	$103.80M	$137.64M	$180.15M	$363.50M	$134.20M	$112.95M	$179.56M	$347.55M	$146.78M	$133.90M	$159.99M	$527.64M	$199.36M	$178.64M	$175.37M	$436.40M	$168.88M	$124.30M
# Analysts	1	1	1	1	1	1	1	1	3	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.76%	0.96%	1.23%	0.99%	0.19%	0.91%	1.18%	1.69%	0.46%	1.06%	1.10%	1.16%	1.02%	0.97%	1.02%

GoHealth's average Quarter revenue forecast for Mar 24 based on 1 analysts is $180.15M, with a low forecast of $180.15M, and a high forecast of $180.15M. GOCO's average Quarter revenue forecast represents a -34.89% decrease compared to the company's last Quarter revenue of $276.70M (Dec 23).

GoHealth EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
# Analysts	1	1	1	1	1	1	1	1	3	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$15.06M	$-37.98M	$-53.02M	$17.82M	$-109.30M	$-20.81M	$-49.62M	$577.00K	$-483.63M	$12.73M	$21.99M	$31.93M	$69.66M	$-22.95M	$10.62M
Avg Forecast	$-13.15M	$-12.70M	$-12.27M	$-11.85M	$-28.99M	$-9.94M	$-9.91M	$-14.76M	$-26.39M	$-8.70M	$-11.54M	$-14.66M	$-29.60M	$-11.25M	$-9.47M	$-15.05M	$-29.13M	$-265.52K	$-242.21K	$16.22M	$-954.48K	$-360.63K	$-323.15K	$35.13M	$-789.42K	$-305.49K	$9.79M
High Forecast	$-12.76M	$-12.33M	$-11.91M	$-11.50M	$-28.14M	$-9.64M	$-9.62M	$-14.32M	$-25.64M	$-8.44M	$-11.20M	$-14.66M	$-29.57M	$-10.92M	$-9.19M	$-14.61M	$-28.27M	$-265.52K	$-242.21K	$19.47M	$-954.48K	$-360.63K	$-323.15K	$42.15M	$-789.42K	$-305.49K	$11.75M
Low Forecast	$-13.74M	$-13.27M	$-12.82M	$-12.38M	$-30.30M	$-10.38M	$-10.36M	$-15.42M	$-27.79M	$-8.95M	$-12.06M	$-14.66M	$-29.63M	$-11.75M	$-9.89M	$-15.73M	$-30.44M	$-265.52K	$-242.21K	$12.98M	$-954.48K	$-360.63K	$-323.15K	$28.10M	$-789.42K	$-305.49K	$7.83M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-0.51%	3.38%	5.60%	-1.18%	3.75%	78.38%	204.87%	0.04%	506.69%	-35.30%	-68.06%	0.91%	-88.25%	75.11%	1.08%

1 analysts predict GOCO's average Quarter EBITDA for Mar 24 to be $-14.66M, with a high of $-14.66M and a low of $-14.66M. This is -197.32% lower than GoHealth's previous annual EBITDA (Dec 23) of $15.06M.

GoHealth Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
# Analysts	1	1	1	1	1	1	1	1	3	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-1.23M	$-56.20M	$-70.23M	$-22.54M	$-150.74M	$-40.15M	$-43.82M	$-37.24M	$-439.59M	$-20.18M	$-11.99M	$-2.09M	$35.96M	$-56.42M	$-22.87M
Avg Forecast	$29.74M	$-49.72M	$-39.80M	$-9.48M	$16.45M	$-37.41M	$-32.74M	$-15.86M	$14.42M	$-44.40M	$-38.01M	$-14.39M	$30.88M	$-40.01M	$-42.55M	$-23.07M	$19.39M	$-42.94M	$-30.45M	$-8.99M	$31.32M	$-12.61M	$-7.31M	$-2.30M	$70.64M	$-2.22M	$-21.10M
High Forecast	$31.49M	$-47.82M	$-38.29M	$-9.12M	$17.42M	$-35.99M	$-31.49M	$-15.26M	$21.00M	$-42.71M	$-36.57M	$-13.84M	$32.12M	$-38.49M	$-40.93M	$-22.19M	$20.53M	$-42.94M	$-30.45M	$-7.19M	$31.32M	$-12.61M	$-7.31M	$-1.84M	$70.64M	$-2.22M	$-16.88M
Low Forecast	$28.61M	$-52.63M	$-42.14M	$-10.03M	$15.82M	$-39.61M	$-34.66M	$-16.79M	$6.59M	$-47.00M	$-40.24M	$-15.23M	$29.52M	$-42.36M	$-45.04M	$-24.42M	$18.65M	$-42.94M	$-30.45M	$-10.79M	$31.32M	$-12.61M	$-7.31M	$-2.76M	$70.64M	$-2.22M	$-25.32M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-0.04%	1.40%	1.65%	0.98%	-7.77%	0.94%	1.44%	4.14%	-14.04%	1.60%	1.64%	0.91%	0.51%	25.41%	1.08%

GoHealth's average Quarter net income forecast for Mar 21 is $-2.30M, with a range of $-2.76M to $-1.84M. GOCO's average Quarter net income forecast represents a -106.39% decrease compared to the company's last Quarter net income of $35.96M (Dec 20).

GoHealth SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
# Analysts	1	1	1	1	1	1	1	1	3	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$100.24M	$52.38M	$77.12M	$68.36M	$81.82M	$48.27M	$82.82M	$113.25M	$125.22M	$183.21M	$154.90M	$130.89M	$185.90M	$311.81M	$66.09M
Avg Forecast	$58.67M	$56.68M	$54.75M	$52.88M	$129.41M	$44.35M	$44.25M	$65.86M	$117.77M	$38.82M	$51.49M	$65.41M	$132.13M	$50.20M	$42.25M	$67.17M	$130.01M	$53.30M	$48.62M	$136.31M	$191.59M	$72.39M	$64.86M	$143.98M	$158.46M	$61.32M	$60.97M
High Forecast	$61.32M	$59.23M	$57.22M	$55.27M	$135.24M	$46.35M	$46.25M	$68.84M	$124.04M	$39.96M	$53.81M	$65.41M	$132.26M	$52.46M	$44.16M	$70.20M	$135.87M	$53.30M	$48.62M	$163.57M	$191.59M	$72.39M	$64.86M	$172.77M	$158.46M	$61.32M	$73.17M
Low Forecast	$56.96M	$55.02M	$53.14M	$51.33M	$125.62M	$43.05M	$42.95M	$63.94M	$114.44M	$37.69M	$49.98M	$65.41M	$131.99M	$48.73M	$41.01M	$65.20M	$126.20M	$53.30M	$48.62M	$109.05M	$191.59M	$72.39M	$64.86M	$115.18M	$158.46M	$61.32M	$48.78M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.76%	1.04%	1.83%	1.02%	0.63%	0.91%	1.70%	0.83%	0.65%	2.53%	2.39%	0.91%	1.17%	5.09%	1.08%

GoHealth's average Quarter SG&A projection for Mar 24 is $65.41M, based on 1 Wall Street analysts, with a range of $65.41M to $65.41M. The forecast indicates a -34.74% fall compared to GOCO last annual SG&A of $100.24M (Dec 23).

GoHealth EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
# Analysts	1	1	1	1	1	1	1	1	3	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-0.13	$-5.92	$-7.70	$-2.51	$-16.95	$-4.55	$-5.28	$-4.81	$-57.32	$-2.66	$-1.76	$-0.34	$1.68	$-10.05	$-4.24
Avg Forecast	$2.04	$-3.41	$-2.73	$-0.65	$1.13	$-2.57	$-2.25	$-1.09	$0.99	$-3.04	$-2.61	$-0.99	$2.12	$-2.74	$-2.92	$-1.58	$1.33	$-4.31	$-3.05	$-1.27	$3.14	$-1.26	$-0.73	$-0.06	$7.08	$-0.22	$-0.54
High Forecast	$2.16	$-3.28	$-2.63	$-0.63	$1.19	$-2.47	$-2.16	$-1.05	$1.44	$-2.93	$-2.51	$-0.95	$2.20	$-2.64	$-2.81	$-1.52	$1.41	$-4.31	$-3.05	$-1.27	$3.14	$-1.26	$-0.73	$-0.06	$7.08	$-0.22	$-0.54
Low Forecast	$1.96	$-3.61	$-2.89	$-0.69	$1.09	$-2.72	$-2.38	$-1.15	$0.45	$-3.22	$-2.76	$-1.04	$2.02	$-2.91	$-3.09	$-1.67	$1.28	$-4.31	$-3.05	$-1.27	$3.14	$-1.26	$-0.73	$-0.06	$7.08	$-0.22	$-0.54
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-0.06%	2.16%	2.64%	1.59%	-12.74%	1.06%	1.73%	3.79%	-18.25%	2.10%	2.40%	5.28%	0.24%	45.16%	7.92%

According to 1 Wall Street analysts, GoHealth's projected average Quarter EPS for Mar 21 is $-0.06, with a low estimate of $-0.06 and a high estimate of $-0.06. This represents a -103.83% decrease compared to GOCO previous annual EPS of $1.68 (Dec 20).

GoHealth Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
EHTH	eHealth	-	-	48.08%	Buy
GOCO	GoHealth	-	-	13.04%
BRP	Baldwin Insurance Group	-	-	-5.08%	Buy
WTW	Willis Towers Watson Public Limited Company	-	-	-6.89%	Buy
AON	Aon	-	-	-9.03%	Hold
MMC	Marsh & McLennan Companies	-	-	-11.17%	Hold
AJG	Arthur J. Gallagher	-	-	-14.94%	Buy
BRO	Brown & Brown	-	-	-15.76%	Buy
SLQT	SelectQuote	-	-	-16.86%	Buy

GOCO Forecast FAQ

Will GoHealth stock go up soon?

According to Wall Street analysts' prediction for GOCO stock, the company can go up by 13.04% (from the last price of $11.5 to the average price target of $13), up by 13.04% based on the highest stock price target, and up by 13.04% based on the lowest stock price target.

Can GoHealth stock reach $20?

GOCO's average twelve months analyst stock price target of $13 does not support the claim that GoHealth can reach $20 in the near future.

What are GoHealth's analysts' financial forecasts?

GoHealth's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $781.77M (high $817.05M, low $758.87M), average EBITDA is $-63.599M (high $-61.736M, low $-66.468M), average net income is $-69.567M (high $-65.327M, low $-75.238M), average SG&A $283.87M (high $296.67M, low $275.55M), and average EPS is $-4.771 (high $-4.481, low $-5.16). GOCO's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $614.08M (high $641.79M, low $596.09M), average EBITDA is $-49.956M (high $-48.493M, low $-52.21M), average net income is $-69.255M (high $-63.741M, low $-76.194M), average SG&A $222.98M (high $233.04M, low $216.44M), and average EPS is $-4.75 (high $-4.372, low $-5.226).

Did the GOCO's actual financial results beat the analysts' financial forecasts?

Based on GoHealth's last annual report (Dec 2023), the company's revenue was $734.67M, which missed the average analysts forecast of $803.47M by -8.56%. Apple's EBITDA was $-81.681M, beating the average prediction of $-65.364M by 24.96%. The company's net income was $-151M, beating the average estimation of $-74.743M by 102.39%. Apple's SG&A was $298.11M, beating the average forecast of $291.74M by 2.18%. Lastly, the company's EPS was $-16.28, beating the average prediction of $-5.126 by 217.57%. In terms of the last quarterly report (Dec 2023), GoHealth's revenue was $276.7M, missing the average analysts' forecast of $363.88M by -23.96%. The company's EBITDA was $15.06M, missing the average prediction of $-29.603M by -150.87%. GoHealth's net income was $-1.226M, missing the average estimation of $30.88M by -103.97%. The company's SG&A was $100.24M, missing the average forecast of $132.13M by -24.13%. Lastly, the company's EPS was $-0.13, missing the average prediction of $2.12 by -106.14%